ROCCO, PAOLO
 Distribuzione geografica
Continente #
EU - Europa 5.614
NA - Nord America 4.829
AS - Asia 3.452
SA - Sud America 1.011
AF - Africa 167
OC - Oceania 119
Continente sconosciuto - Info sul continente non disponibili 1
Totale 15.193
Nazione #
US - Stati Uniti d'America 4.255
IT - Italia 1.486
GB - Regno Unito 1.426
CN - Cina 931
SG - Singapore 719
BR - Brasile 451
DE - Germania 416
FR - Francia 323
MX - Messico 304
IN - India 277
RU - Federazione Russa 267
HK - Hong Kong 226
CA - Canada 224
ES - Italia 219
NL - Olanda 217
VN - Vietnam 199
AR - Argentina 189
TH - Thailandia 189
SE - Svezia 161
PL - Polonia 150
BD - Bangladesh 148
CO - Colombia 148
TR - Turchia 128
JP - Giappone 114
FI - Finlandia 109
IE - Irlanda 107
AU - Australia 101
KR - Corea 100
DK - Danimarca 99
CL - Cile 95
PT - Portogallo 90
ID - Indonesia 76
CH - Svizzera 70
BE - Belgio 62
GR - Grecia 61
UA - Ucraina 61
ZA - Sudafrica 60
EC - Ecuador 48
TW - Taiwan 48
IL - Israele 47
CZ - Repubblica Ceca 46
IQ - Iraq 41
PE - Perù 41
IR - Iran 34
AT - Austria 32
RO - Romania 31
PH - Filippine 30
PK - Pakistan 27
SI - Slovenia 26
BG - Bulgaria 25
EU - Europa 23
UG - Uganda 23
UY - Uruguay 23
SA - Arabia Saudita 21
HR - Croazia 19
MT - Malta 19
NZ - Nuova Zelanda 18
NO - Norvegia 17
LB - Libano 16
MA - Marocco 15
NP - Nepal 15
MY - Malesia 14
SK - Slovacchia (Repubblica Slovacca) 13
CR - Costa Rica 11
RS - Serbia 11
EG - Egitto 9
HU - Ungheria 9
KW - Kuwait 9
BY - Bielorussia 8
LT - Lituania 8
TT - Trinidad e Tobago 8
GH - Ghana 7
JM - Giamaica 7
MK - Macedonia 7
CI - Costa d'Avorio 6
NG - Nigeria 6
AZ - Azerbaigian 5
GE - Georgia 5
LV - Lettonia 5
MW - Malawi 5
PY - Paraguay 5
TN - Tunisia 5
UZ - Uzbekistan 5
AM - Armenia 4
JO - Giordania 4
LU - Lussemburgo 4
PA - Panama 4
TZ - Tanzania 4
VE - Venezuela 4
BA - Bosnia-Erzegovina 3
BJ - Benin 3
DZ - Algeria 3
GT - Guatemala 3
KE - Kenya 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
ME - Montenegro 3
PR - Porto Rico 3
PS - Palestinian Territory 3
AE - Emirati Arabi Uniti 2
Totale 15.167
Città #
Southend 1.015
Ashburn 429
Milan 408
Singapore 404
Redwood City 235
Chandler 233
San Jose 195
Hong Kong 184
Beijing 179
Fairfield 179
Seattle 144
Wilmington 140
Dallas 128
Houston 127
Woodbridge 123
Council Bluffs 117
London 107
Santa Clara 100
Princeton 97
Dublin 95
Los Angeles 95
Rome 86
Bogotá 74
Ann Arbor 71
Cambridge 70
Helsinki 65
Dearborn 64
Nanjing 62
São Paulo 62
Bengaluru 60
Ho Chi Minh City 60
Hefei 57
New York 55
Buenos Aires 50
Guangzhou 50
Bangkok 49
Lauterbourg 49
Santiago 48
Hangzhou 47
Mountain View 46
Hanoi 41
Tokyo 41
Shenyang 40
Jakarta 37
Buffalo 35
Mexico 35
Madrid 34
Shanghai 34
Moscow 33
Amsterdam 32
Toronto 32
Valdivia 32
Des Moines 31
Chicago 30
Redmond 30
Berlin 29
Boardman 29
Lima 29
Mumbai 29
Valencia 28
Mexico City 27
Ottawa 27
Istanbul 26
Jacksonville 26
Phoenix 26
Bologna 25
Paris 25
Dong Ket 24
Jinan 24
Quito 24
Duncan 23
Warsaw 23
Medellín 22
Melbourne 22
Athens 21
Cangzhou 21
Federal 21
San Diego 20
Turin 20
Washington 20
Delhi 19
Hyderabad 19
Mbarara 19
Munich 19
Naples 19
Seoul 19
Lisbon 17
Montevideo 17
Polska 17
Rio de Janeiro 17
Serra 17
Taipei 17
Brussels 16
City of London 16
Columbus 16
Johannesburg 16
Sydney 16
Vienna 16
Wroclaw 16
Hamburg 15
Totale 7.330
Nome #
Extraction Method and Analysis of Cannabinoids in Cannabis Olive Oil Preparations 4.591
Glatiramer acetate : a complex drug beyond biologics 810
Do laws impact opioids consumption? A breakpoint analysis based on Italian sales data 615
The safety of tattoo inks: Possible options for a common regulatory framework 512
Copies of nonbiological complex drugs: generic, hybrid or biosimilar? 458
Marketing authorisations for unmet medical needs: A critical appraisal of regulatory pathways in the European Union 447
Biosimilar switching and related medical liability 355
The management of upper gastrointestinal symptoms: A study on community pharmacies in Italy 341
Rationalizing the design of hyaluronic acid-decorated liposomes for targeting epidermal layers: a combination of molecular dynamics and experimental evidence 337
Molecular Dynamics as a tool for in silico screening of skin permeability 333
Regulatory aspects and quality controls of polymer-based parenteral long-acting drug products: the challenge of approving copies 327
Medicinali equivalenti in Italia: le ragioni della diffidenza di medici e farmacisti = Equivalent medicinal products in Italy: the reasons for the prudence of physicians and pharmacists 323
DEVELOPMENT OF ALTERNATIVE METHODS TO IN VIVO AND IN VITRO ASSAYS FOR THE PREDICTION OF SKIN PERMEABILITY TO CHEMICAL COMPOUNDS 309
The constrained prescription, interchangeability and substitution of biosimilars 288
Topical Treatment of Infantile Haemangiomas: A Comparative Study on the Selection of a Semi-Solid Vehicle 267
Il Titolo II del T.U.L.S. del 1934 : norme ancora in vigore 265
Biosimilari: quale denominazione comune 258
Poly(methyl methacrylate) salt as film forming material to design orodispersible films 258
Biosimilars: Regulatory Aspects in the USA and the EU 230
Community Pharmacist's Role in Detecting Low Back Pain, and Patient Attitudes-A Cross-Sectional Observational Study in Italian Community Pharmacies 199
Preserving the Integrity of Liposomes Prepared by Ethanol Injection upon Freeze-Drying: Insights from Combined Molecular Dynamics Simulations and Experimental Data 197
Biosimilars in European Union: State of the Art 196
La farmacovigilanza 193
Biosimilars and Regulatory Authorities 176
Norme sull’A.i.c. dei medicinali di origine industriale per uso umano 169
Patient-managed digital medical devices: Do we need further regulation? 167
Old active ingredients in new medicinal products: is the regulatory path coherent with patients' expectations? 167
Simulation data for an estimation of the maximum theoretical value and confidence interval for the correlation coefficient 164
Aspetti regolatori dei medicinali biotecnologici 161
Medicinal products meet medical devices: Classification and nomenclature issues arising from their combined use 157
I medicinali biosimilari in commercio nell’Unione europea a due anni dalla loro introduzione 157
Regulatory aspects of 3D printing systems in healthcare 150
L’informazione scientifica agli operatori sanitari 148
Which International Nonproprietary Name (INN) for biosimilar products? 142
La disciplina dei medicinali biosimilari in Europa 142
Aspetti regolatori dei biosimilari 142
The regulatory framework of biosimilars in the European Union 139
La normativa sulla produzione e la vendita dei liquidi per sigarette elettroniche 139
Insuline biosimilari: aspetti regolatori e impatto degli analoghi ad azione rapida 137
La pubblicità al grande pubblico 136
I farmaci innovativi: disciplina nazionale attesa, per il 2017, per la copertura del fondo 134
Theoretical skin permeability studies with molecular dynamics 132
Back to gene therapy: bringing the EU regulation into the future 128
Risk management of in-hospital administration of anticancer drugs: impact of Raccomandazione 14 from the Italian Ministry of Health 125
Recenti cambiamenti regolatori : classificazione in materia di fornitura dei medicinali 109
AIC dei medicinali omeopatici : 'dossier' e questione delle materie prime 107
La produzione e metodi analitici 103
Riflessioni sulla corretta conservazione dei medicinali e relative responsabilità 98
Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010) 97
Poly(methyl methacrylate) salt to design orodispesible films 88
On-body drug delivery systems: State-of-the-art technologies, clinical application, and future perspectives 86
Totale 15.909
Categoria #
all - tutte 35.381
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.381


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.428 159 108 102 94 119 112 103 94 123 110 132 172
2022/20231.447 136 110 155 123 153 216 64 95 153 63 107 72
2023/20241.232 70 96 89 88 153 63 97 95 69 119 130 163
2024/20251.849 84 152 66 127 223 105 83 177 127 198 156 351
2025/20263.376 342 212 333 260 265 356 467 136 255 273 290 187
2026/202717 17 0 0 0 0 0 0 0 0 0 0 0
Totale 15.909